Introducing the first non-invasive nanofluid breathing aid for respiratory distress and advanced regenerative biomaterials for superior topical oxygen delivery – all powered by our nanotechnology platform.
Swaza is pioneering a first-of-its-kind oxygen nanotherapy, enabling O₂ delivery and CO₂ removal through fibrotic lung tissue – without invasive ventilation. Our patented nanofluid technology is the only solution capable of dynamic gas exchange in compromised lungs, addressing a critical gap in respiratory care.
With a $56B U.S. market opportunity, Swaza is poised to revolutionize treatment for millions suffering from hypoxemia, COPD, IPF, and other respiratory conditions.